KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incyte (INCY) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Incyte (INCY) over the last 16 years, with Q3 2025 value amounting to $2.5 billion.

  • Incyte's Cash & Equivalents rose 8825.16% to $2.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 billion, marking a year-over-year increase of 8825.16%. This contributed to the annual value of $1.7 billion for FY2024, which is 4747.49% down from last year.
  • According to the latest figures from Q3 2025, Incyte's Cash & Equivalents is $2.5 billion, which was up 8825.16% from $2.0 billion recorded in Q2 2025.
  • Incyte's Cash & Equivalents' 5-year high stood at $3.3 billion during Q1 2024, with a 5-year trough of $987.3 million in Q2 2024.
  • Its 5-year average for Cash & Equivalents is $2.3 billion, with a median of $2.3 billion in 2022.
  • In the last 5 years, Incyte's Cash & Equivalents crashed by 6846.84% in 2024 and then soared by 9801.31% in 2025.
  • Over the past 5 years, Incyte's Cash & Equivalents (Quarter) stood at $2.1 billion in 2021, then skyrocketed by 43.45% to $3.0 billion in 2022, then grew by 8.88% to $3.2 billion in 2023, then plummeted by 47.47% to $1.7 billion in 2024, then skyrocketed by 45.45% to $2.5 billion in 2025.
  • Its Cash & Equivalents stands at $2.5 billion for Q3 2025, versus $2.0 billion for Q2 2025 and $1.9 billion for Q1 2025.